Company attributes
Founder
AngelList URL
Pitchbook URL
Legal Name
Dicerna Pharmaceuticals, Inc.
Parent Organization
Legal classification
Date Incorporated
2006
Number of Employees (Ranges)
201 – 5000
Email Address
medicalinfo@dicerna.com0
Number of Employees
3010
Full Address
75 Hayden Ave Lexington, MA, 02421 United States0
4949 Pearl East Circle Suite 100 Boulder, CO 803010
33 Hayden Avenue Lexington, MA 024210
CIK Number
Place of Incorporation
Investors
DUNS Number
009645240
IRS Number
205,993,6090
Founded Date
2007
Total Funding Amount (USD)
85,000,000
Latest Funding Round Date
July 31, 2013
Competitors
Stock Symbol
DRNA
Exchange
Key People
Latest Funding Type
CAGE Code
621R80
Patents Assigned (Count)
58
Legal Entity Identifier
Wellfound ID
Country
Headquarters
Other attributes
Acquirer
Company Operating Status
Active
Contact Page URL
SIC Code
2,8340
Wikidata ID
Dicerna Pharmaceuticals was founded in 2006 and uses its GalXC technology platform to develop RNA interference (RNAi) therapies for treating rare and common inherited diseases.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
